If human trials with the compound show safety and efficacy, NNMT inhibitors like 5-amino-1MQ could serve to prevent and/or slow age-related muscle deterioration in humans, a tantalizing prospect
Research overview Other vial-size protocols Related protocols and comparisons
However, these positive outcomes were not consistently observed across all GLP-1RA studies
According to a study published in BMC Medicine, around 4.9 million British adults are estimated to have recently used or expressed interest in using glucagon-like peptide-1 (GLP-1) or dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist medications for weight loss
Continue for 412 weeks depending on severity and response
Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A, et al: Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism